CoChat

Adiponectin: An Indispensable Molecule in Rosiglitazone Cardioprotection Following Myocardial Infarction

Open access
Tao, Ling, Wang, Yajing, Gao, Erhe, Zhang, Hangxiang, Yuan, Yuexing, Lau, Wayne B., Chan, Lawrence, Koch, Walter J., Ma, Xin L. · 2010 · Circulation Research
Cited by 89

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Rationale : Patients treated with peroxisome proliferator-activated receptor (PPAR)-γ agonist manifest favorable metabolic profiles associated with increased plasma adiponectin (APN). However, whether increased APN production as a result of PPAR-γ agonist treatment is an epiphenomenon or is causatively related to the cardioprotective actions of PPAR-γ remains unknown. Objective : To determine the role of APN in rosiglitazone (RSG) cardioprotection against ischemic heart injury. Methods and Results : Adult male wild-type (WT) and APN knockdown/knockout (APN +/− and APN −/− ) mice were treated with vehicle or RSG (20 mg/kg per day), and subjected to coronary artery ligation 3 days after beginning treatment. In WT mice, RSG (7 days) significantly increased adipocyte APN expression, elevated plasma APN levels (2.6-fold), reduced infarct size (17% reduction), decreased apoptosis (0.23±0.02% versus 0.47±0.04% TUNEL-positive in remote nonischemic area), attenuated oxidative stress (48.5% reduction), and improved cardiac function ( P <0.01). RSG-induced APN production and cardioprotection were significantly blunted ( P <0.05 versus WT) in APN +/− , and completely lost in APN −/− ( P >0.05 versus vehicle-treated APN −/− mice). Moreover, treatment with RSG for up to 14 days significantly improved the postischemic survival rate of WT mice ( P <0.05 versus vehicle group) but not APN knockdown/knockout mice. Conclusions : The cardioprotective effects of PPAR-γ agonists are critically dependent on its APN stimulatory action, suggesting that under pathological conditions where APN expression is impaired (such as advanced type 2 diabetes), the harmful cardiovascular effects of PPAR-γ agonists may outweigh its cardioprotective benefits.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circresaha.109.211797

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 89

Metadata

Authors
Tao, L., Wang, Y., Gao, E., Zhang, H., Yuan, Y., Lau, W. B., Chan, L., Koch, W. J., & Ma, X. L.
Venue
Circulation Research
Published
2010-02-05
Volume
106
Issue
2
Pages
409-417
ISSN
  • 0009-7330 (ISSN-L)
  • 1524-4571
OpenAlex
W2085414252
Cited by
89
References
5
FWCI
3.60
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Adiponectin: An Indispensable Molecule in Rosiglitazone Cardioprotection Following Myocardial Infarction. https://app.cochat.ai/papers/10.1161/circresaha.109.211797
The paper
Tao, L., Wang, Y., Gao, E., Zhang, H., Yuan, Y., Lau, W. B., Chan, L., Koch, W. J., & Ma, X. L. (2010). Adiponectin: An Indispensable Molecule in Rosiglitazone Cardioprotection Following Myocardial Infarction. Circulation Research. https://doi.org/10.1161/circresaha.109.211797

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.